 |
|
Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
Rui Shi, Minghua Wang
Clin Mol Hepatol. 2025;31(2):e137-e139. Published online 2025 Jan 9 DOI: https://doi.org/10.3350/cmh.2024.1159
|
|
Citations to this article as recorded by
 Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
Soon Kyu Lee, Jong Young Choi
Clinical and Molecular Hepatology.2025; 31(2): e212. CrossRef
|